Martin John Kendall

Martin John Kendall's AcademicInfluence.com Rankings

Martin John Kendall

Computer Science

#8073

World Rank

#8492

Historical Rank

Machine Learning

#3198

World Rank

#3237

Historical Rank

Artificial Intelligence

#3501

World Rank

#3551

Historical Rank

computer-science Degrees

Martin John Kendall

Mathematics

#7025

World Rank

#9630

Historical Rank

Operations Research

#68

World Rank

#70

Historical Rank

Measure Theory

#1804

World Rank

#2208

Historical Rank

mathematics Degrees

Download Badge

Computer Science
Mathematics

Martin John Kendall's Degrees

PhD Computer Science University of Nottingham
Bachelors Mathematics University of Nottingham

Similar Degrees You Can Earn

Why Is Martin John Kendall Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Martin John Kendall's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The oxidation hypothesis of atherosclerosis (1994) (463)
-Blockers and Sudden Cardiac Death (1995) (239)
The pharmacokinetics of diclofenac sodium following intravenous and oral administration (2004) (200)
Corticosteroids: do they damage the cardiovascular system? (1994) (146)
Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. (2004) (138)
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. (1979) (124)
Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. (1996) (122)
Growth hormone treatment for growth hormone deficient adults (1996) (121)
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. (2001) (111)
Metabolic effects of β2‐agonists (1992) (101)
An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect® (1998) (99)
Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis. (1985) (93)
Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? (1970) (86)
Low-density lipoprotein subfraction profiles in chronic renal failure. (1998) (84)
The effect of ageing on plasma pethidine concentration. (1975) (80)
Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. (1986) (79)
The impact of therapeutic doses of paracetamol on serum total antioxidant capacity (2003) (72)
Nervous System Involvement in Ankylosing Spondylitis (1974) (72)
The effect of age on the pharmacokinetics of metoprolol and its metabolites. (1981) (69)
Responsiveness to beta-adrenergic receptor stimulation: the effects of age are cardioselective. (1982) (68)
The role of beta receptor blockade in preventing sudden death. (1992) (68)
Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus. (1999) (66)
Clinical relevance of pharmacokinetic differences between beta blockers. (1997) (63)
One-hour blood-xylose screening-test for coeliac disease in infants and young children. (1973) (62)
Serum biochemical values in rheumatoid disease. (1971) (59)
GLUTEN SUBFRACTIONS IN CŒLIAC DISEASE (1972) (59)
The influence of age on the xylose absorption test (1970) (58)
beta Blockade after myocardial infarction. Beta blockers have key role in reducing morbidity and mortality after infarction. (2000) (58)
Exercise, fitness and health. (1992) (55)
Antioxidant therapy for the prevention of cardiovascular disease. (1999) (53)
Nitric oxide in acute ischaemic stroke: a target for neuroprotection (1999) (51)
Controlled Release Metoprolol (1991) (51)
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions. (1983) (48)
Particle size: the key to the atherogenic lipoprotein? (1994) (48)
The influence of food on the absorption of diclofenac after single and multiple oral doses (2004) (48)
Variations in responses to non-steroidal anti-inflammatory drugs. (1982) (45)
Review article: esomeprazole − the first proton pump inhibitor to be developed as an isomer (2003) (45)
Probenecid: an unexplained effect on cephalosporin pharmacology. (1979) (45)
Metoprolol pharmacokinetics and the oral contraceptive pill. (1982) (43)
Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration. (1987) (43)
Pharmacokinetic studies on diclofenac sodium in young and old volunteers. (1978) (41)
Effect of Aspirin on Renal Clearance of 125I-Diatrizoate (1971) (40)
ENALAPRIL IN RAYNAUD'S PHENOMENON (1988) (39)
Pharmacokinetic Considerations of Formulation: Extended-Release Metoprolol Succinate in the Treatment of Heart Failure (2003) (39)
A comparison of the β1‐selectivity of three β1‐selective β‐blockers (2003) (37)
Malabsorption in rheumatoid disease. (1971) (36)
Haematology and Biochemistry of Ankylosing Spondylitis (1973) (35)
Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol). (1979) (35)
Acute effects of beta blockade and exercise on mood and anxiety. (1996) (35)
Xylose Test: Effect of Aspirin and Indomethacin (1971) (34)
A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium (1980) (34)
Effect of age on plasma propranolol levels [letter] (1980) (34)
Effects of inflammatory disease on plasma oxprenolol concentrations. (1979) (34)
Does paracetamol cause asthma? (2003) (34)
A comparison of the beta1-selectivity of three beta1-selective beta-blockers. (2003) (34)
An assessment of gastric emptying by breathalyser. (1974) (33)
Determination of total monohydroxylated metabolites of diclofenac in urine by electron-capture gas-liquid chromatography. (1980) (33)
Metabolic effects of beta 2-agonists. (1992) (33)
A quantitative gas-liquid chromatographic method for the determination of pethidine and its metabolites, norpethidine and pethidine N-oxide in human biological fluids (1974) (33)
A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects. (1976) (31)
The influence of drugs and disease activity on biochemical and haematological data in rheumatoid arthritis. (1975) (30)
Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents. (1981) (30)
Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment. (1991) (30)
Medical errors. Medical schools can teach safe drug prescribing and administration. (2001) (29)
Comparison of plasma and saliva levels of metoprolol and oxprenolol. (1978) (29)
Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis. (1976) (29)
Plasma metoprolol concentrations in young, old and hypertensive subjects. (1977) (29)
Quinidine-induced systemic lupus erythematosus. (1970) (29)
A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol (1980) (28)
Beta-blockers and sudden cardiac death. (1995) (27)
Factors influencing the excretion and relative physiological availability of pethidine in man (1975) (27)
The chest radiograph in ankylosing spondylitis. (1975) (27)
The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol. (1982) (26)
Stroke affecting young men after alcoholic binges. (1985) (26)
The Northwick Park tragedy – protecting healthy volunteers in future first‐in‐man trials (2007) (25)
The influence of sex, body weight, and renal function on the xylose test (1970) (25)
Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol. (1984) (24)
Source and significance of 5-nucleotidase in synovial fluid. (1973) (23)
Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine. (1980) (23)
Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system. (1982) (22)
Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy. (1996) (22)
Testing the practical aspects of therapeutics by objective structured clinical examination (2004) (22)
William Withering and digitalis, 1785 to 1985. (1985) (22)
Effect of amiodarone on mortality (1998) (22)
Behçet's disease presenting as benign intracranial hypertension. (1986) (21)
Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill. (1984) (21)
The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers. (1993) (21)
The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide. (1982) (20)
Effect of age on plasma propranolol levels. (1980) (20)
The impact of a short course of three lipid lowering drugs on fat oxidation during exercise in healthy volunteers. (1993) (20)
Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon. (1986) (20)
Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine. (1980) (20)
The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin. (1979) (20)
Variability of beta-blocker pharmacokinetics in young volunteers (2004) (19)
Gluten subfractions in coeliac disease. (1972) (19)
Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals. (1979) (19)
Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives. (1987) (19)
A single dose study of trazodone with an assessment of its effect on mood and arousal. (1975) (19)
Mecillinam serum levels following intravenous injection: a comparison with pivmecillinam. (1977) (18)
Effect of changes in dietary sodium and potassium on blood pressure and cellular electrolyte handling in young normotensive subjects. (1985) (18)
Insulin resistance ‐ the new goal! (2003) (18)
Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo. (1997) (18)
The intra- and inter-subject variability of Nifedipine pharmacokinetics in young volunteers (2004) (18)
Pharmacokinetics of cephradine given intravenously with and without probenecid. (1981) (18)
Pethidine N‐oxide: a metabolite in human urine (1972) (18)
Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension. (2002) (17)
INHALED BRONCHODILATORS AND HYPOKALAEMIA (1983) (17)
Bacteriology and pharmacokinetics of the new amidino penicillin-mecillinam. (1976) (17)
Pharmacokinetics and pharmacodynamics of isradipine (PN 200-110) in young and elderly patients (1988) (17)
Synovial fluid in ankylosing spondylitis. (1973) (17)
Therapeutic advances: leukotriene antagonists for the treatment of asthma (1999) (17)
The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease (2004) (17)
The Influence of Age on the Pharmacokinetics of Nitrendipine (1987) (16)
The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol. (1984) (16)
Measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid tumours: comparison of different methods of assessing vascularity. (1999) (16)
Metoprolol with and without chlorthalidone in hypertension (1979) (16)
Determination of metoprolol metabolites in plasma and urine by electron-capture gas--liquid chromatography. (1980) (15)
Effect of Atorvastatin on Low-Density Lipoprotein Subfraction Profile (1999) (15)
The cardioprotective role of β‐blockers in patients with diabetes mellitus (2002) (14)
Treatment of hypertension in older adults. (1992) (14)
Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study. (1985) (14)
METOPROLOL—CONTROLLED RELEASE, ZERO ORDER KINETICS (1989) (13)
The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects. (1997) (13)
5-nucleotidase in the serum and synovial fluid of patients with rheumatoid disease. (1971) (13)
A pharmacological and in vitro comparison of three oral cephalosporins. (1979) (13)
Pharmacokinetic interactions between felodipine and metoprolol (2004) (12)
Causality assessment of adverse drug effects: when is rechallenge ethically acceptable? (1999) (12)
Antioxidant therapy – a new therapeutic option for reducing mortality from coronary artery disease (1998) (12)
A comparison of the effects of fluvastatin and bezafibrate on exercise metabolism: a placebo-controlled study in healthy normolipidaemic subjects. (1996) (12)
INVESTIGATION OF THE EFFECTS OF β‐2 STIMULATION ON FREE FATTY ACIDS IN MAN (1991) (12)
Oxprenolol: clinical pharmacology, pharmacokinetics, and pharmacodynamics. (1983) (12)
Beta-blockers in heart failure. 2. Mode of action. (1945) (12)
A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers. (1985) (12)
Rhabdomyolysis with HMG CoA reductase inhibitors: a class effect? (2001) (12)
A PHARMACOKINETIC COMPARISON OF IBUPROFEN SUSTAINED‐RELEASE TABLETS GIVEN TO YOUNG and ELDERLY PATIENTS (1990) (11)
A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients (2004) (11)
The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration (2004) (11)
Clinical trial data on the cardioprotective effects of beta-blockade (2000) (11)
Drug-induced malabsorption. (1973) (11)
Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man. (1976) (11)
Exercise metabolism during 1 hour of treadmill walking while taking high and low doses of propranolol, metoprolol, or placebo (1995) (11)
Testing gluten sensitivity by the xylose test. (1972) (11)
Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure. (1995) (11)
The effect of age on the pharmacokinetics of oxprenolol. (1982) (10)
LONG‐TERM THERAPEUTIC EFFICACY WITH ONCE‐DAILY ISOSORBIDE‐5‐MONONITRATE (IMDUR®) (1990) (10)
The heart protection study: statins for all those at risk? (2002) (10)
Lack of effect of propranolol and metoprolol on glucose tolerance in maturity-onset diabetics. (1980) (10)
Nifedipine in the treatment of difficult hypertensives (2004) (10)
Therapeutic advances: protease inhibitors for the treatment of HIV‐1 infection (1997) (10)
Cost analysis of once‐daily ISMN versus twice‐daily ISMN or transdermal patch for nitrate prophylaxis (1997) (10)
The effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of metoprolol (1988) (10)
Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation (1979) (10)
Effect of propranolol on thyroid homeostasis of healthy volunteers. (1985) (10)
Evaluation of simple method to check compliance with antihypertensive drug therapy. (1980) (10)
Serum immunoglobulins in ankylosing spondylitis. (1973) (9)
Conventional versus newer antihypertensive therapies—a draw (1999) (9)
Inter- and intra-subject variability of nitrendipine and the effects of food (2004) (9)
Impact of beta 1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockers. (1987) (9)
Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs. (1993) (9)
Treatment with β‐blockers—the value of an even plasma concentration over 24 h (1997) (9)
The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva. (1981) (9)
Causality Assessment of Adverse Effects (2001) (9)
Pancreatic pseudocyst with gastric and colonic connections treated conservatively (1980) (9)
Sodium transport across erythrocyte membranes in diabetes mellitus. (1986) (9)
Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo. (1994) (9)
Non‐lipid properties of statins (1999) (8)
Lack of effect of H2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime. (1994) (8)
Therapeutic advances: riluzole for the treatment of motor neurone disease (1996) (8)
Changes in Circulating Amino Acid Precursors of Brain Monoamine Synthesis and Prolactin during Prolonged Exhaustive Exercise in Endurance-Trained and Non-Trained Subjects (1994) (8)
Beta-receptor blockade in preventing sudden death (1993) (8)
The Anglo‐Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (2006) (8)
Possible mechanisms of action in the positive effect of β blockers in heart failure (1999) (8)
Pharmacology of third-generation beta-blockers: greater benefits, fewer risks. (1989) (7)
Will drugs help patients with Alzheimer's disease? (1979) (7)
Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants. (1994) (7)
Blood sugar and beta-blockers. (1976) (7)
Some observations and speculations on the factors influencing the concentration of phenylbutazone in synovial fluid. (1982) (7)
Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man. (1974) (7)
β-Blockers in the Management of Hypertension in Patients with Type 2 Diabetes Mellitus (2012) (6)
Short-term antioxidant supplementation reduces oxidative stress in elderly patients with type 2 diabetes mellitus—a pilot study (2002) (6)
Oral glucose in reduction of jejunostomy effluent. (1971) (6)
Difficult Hypertension: Practical management and decision making (1995) (6)
CALCIUM ANTAGONISM—WITH SPECIAL REFERENCE TO DILTIAZEM (1986) (6)
ANTIPLATELET DRUGS IN THROMBOTIC DISEASE (1977) (6)
Carbidopa does not affect the renal response to atrial natriuretic factor in man. (1989) (6)
The influence of diphenhydramine on the absorption of methaqualone in man. (1974) (6)
Investigation of the effects of beta-2 stimulation on free fatty acids in man. (1991) (6)
An update on nitrate tolerance: can it be avoided? (1992) (6)
Effect of food on the bioavailability of alafosfalin, a new antibacterial agent. (1980) (6)
Therapeutic advantages of AT1 blockers in hypertension (1998) (5)
Pharmacokinetics of pirprofen in young volunteers and elderly patients (2004) (5)
Pharmacokinetic and relative bioavailability studies of cimoxatone in humans. (1984) (5)
Does cholesterol lowering prevent stroke? (1998) (5)
Pilot study to compare the bronchodilator and metabolic responses to terbutaline infusion in seven asthmatic subjects—are they correlated? (1992) (5)
Therapeutic advances: donepezil for the treatment of Alzheimer's disease (1997) (5)
A Risk-Benefit Assessment of Celiprolol in the Treatment of Cardiovascular Disease (1994) (5)
Women with gestational diabetes should be targeted to reduce cardiovascular risk (2002) (5)
A comparison of the β1–selectivity of conventional metoprolol and metoprolol CR during exercise in healthy volunteers (1993) (5)
A metabolic assessment of the beta 1 selectivity of bisoprolol. (1992) (5)
Letter: Daily antihypertensive therapy. (1976) (5)
ALCOHOL AND TREATMENT OF DIABETES (1988) (5)
Diabetes mellitus after mumps * 0 vaccination (2006) (5)
Co‐administration of misoprostol or ranitidine with indomethacin: effects on pharmacokinetics, abdominal symptoms and bowel habit (1992) (5)
THE INTERACTION OF ALCOHOL and ^‐BLOCKERS IN ARTERIAL HYPERTENSION (1990) (5)
THE DISAPPEARING HYPERTENSIVES (1980) (4)
Exercise responses of healthy subjects in the evaluation of cardioselectivity ofβ-blockers (1979) (4)
Vitamin E supplementation (2001) (4)
Intestinal motility and absorption. (1973) (4)
Beta‐blockers in heart failure. 2. Mode of action (2001) (4)
The adrenergic control of lipolysis: development of tolerance to beta-2 receptor stimulation with terbutaline. (1991) (4)
Hypertension in the elderly (1998) (4)
The causes and management of atrial fibrillation (1996) (4)
DIURETIC-INDUCED HYPERTEIGLYCERIDÆMIA (1976) (4)
The effect of flurbiprofen on the responses to frusemide in healthy volunteers. (1983) (4)
The effects of four β-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate (1987) (4)
Prostate cancer and antioxidants (2001) (4)
Frequent paracetamol use linked to asthma (2000) (4)
Adverse interaction between nifedipine and beta-blockade. (1981) (4)
Beta‐blockers in heart failure. 1. Clinical evidence (2000) (4)
Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role? (2001) (4)
Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise (2004) (4)
The effects of selective and non-selective inhibition of cyclo-oxygenase on frusemide-stimulated natriuresis. (1986) (4)
Beta-Adrenoceptor Blocking Drugs and the Elderly (1984) (4)
Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form. (1985) (3)
Potential mechanisms of the cardioprotective effects of beta blockade (1991) (3)
Fluoxetine and chronic fatigue syndrome (1996) (3)
The interaction of alcohol and beta-blockers in arterial hypertension. (1990) (3)
THE PHARMACOKINETICS OF OXPRENOLOL FOLLOWING ORAL AND RECTAL DOSING–A COMPARISON OF DELIVERY SYSTEMS AND ROUTES OF ADMINISTRATION (1987) (3)
Clopidogrel: secondary prevention of vascular ischaemic events. (1998) (3)
DRUG REACTIONS AND THE POOR METABOLISER (1983) (3)
Pharmacokinetics of oxprenolol in the elderly. (1983) (3)
BETA BLOCKERS, BLOOD SUGARS, AND THIAZIDES (1985) (3)
BETA AGONISTS AND POTASSIUM (1985) (3)
One hour blood D-xylose as a screening test for malabsorption in infants and young children. (1972) (3)
Factors influencing the absorption of oxprenolol A pharmacokinetic study (1976) (3)
The incidence of sudden death in post‐myocardial infarction beta‐blocker trials (1999) (3)
A placebo controlled comparison of the effects of pirenzepine and amitriptyline on the tyramine pressor test in healthy volunteers. (1985) (3)
CAPTOPRIL AND HYDROCHLOROTHIAZIDE—A SAFE ANTIHYPERTENSIVE FOR USE IN GENERAL PRACTICE? (1991) (3)
Dissociation of changes in sodium transport in erythrocytes from changes in blood pressure. (1985) (3)
Sick children deserve a better deal (2006) (3)
JAUNDICE AFTER ORAL PENICILLIN (1976) (3)
The role of clinical pharmacology in the development and evaluation of oral controlled-release dosage forms. (1985) (3)
The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers. (1986) (2)
β‐BLOCKERS and BLOOD SUGARS (1979) (2)
Variation in biological availability. (1973) (2)
Coronary artery disease – more disease, more patients, better treatment (2003) (2)
Variability of plasma drug concentrations: Some observations (2004) (2)
Therapeutics needs to be better taught (2002) (2)
Optimizing digoxin dosage: the long winding road (2003) (2)
Gluten provocation and the xylose test in adolescents. (1973) (2)
Bacteria and the xylose test. (1972) (2)
ACE INHIBITION IN THE 1990s (1993) (2)
BETA-BLOCKERS AND DEBRISOQUINE METABOLISER STATUS (1982) (2)
Women in new drug trials. (1982) (2)
Twelve hour (trough) plasma nifedipine concentrations during chronic treatment with nifedipine retard (2004) (2)
The effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents [proceedings]. (1980) (2)
Letter: Gut motility changes causing drug malabsorption. (1974) (2)
The Disposition of Mecillinam and Pivmecillinam in Man (1976) (2)
ASSESSMENT OF β‐1 SELECTIVITY OF BISOPROLOL AND ATENOLOL BY MEANS OF THEIR INFLUENCE ON THE LIPOLYTIC RESPONSE TO AN INFUSION OF TERBUTALINE (1991) (2)
The treatment of elderly hypertensive patients (1993) (2)
THERAPEUTIC PROGRESS–REVIEW XXIX IS THERE A ROLE FOR LOW‐DOSE ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION? (1987) (2)
A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. (1980) (1)
Cardiac arrest: a role for vasopressin (2004) (1)
Quality of Life in Cardiovascular Diseases Emphasis on f 3-Blcker Treatment (2005) (1)
Planning and Protocol (1985) (1)
Non-steroidal anti-inflammatory drugs and frusemide-induced diuresis (1981) (1)
Approaches to Meeting the Criteria for Fixed Dose Antihypertensive Combinations (1995) (1)
A COMPARISON OF THE METABOLIC EFFECTS OF FLOSEQUINAN AND PROPRANOLOL IN PATIENTS WITH NON‐INSULIN‐DEPENDENT DIABETES MELLITUS (1991) (1)
Nitrates: do they have a role in the treatment of asthma? (1988) (1)
ASPIRIN AND PRIMARY PROPHYLAXIS IN MYOCARDIAL INFARCTION (1989) (1)
A pharmacological study of UK-18,892 and amikacin. (1978) (1)
Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris (1997) (1)
The Acute Unwanted Effects of Beta2 Receptor Agonist Therapy (2020) (1)
Is the xylose test worthwhile? (1973) (1)
THE EFFECTOF AGEING ON PLASMA PETHIDINECONCENTRATION (1975) (1)
The effect of some formulation variables on the bioequivalence of methaqualone preparations (1976) (1)
A PHARMACOKINETIC AND PHARMACODYNAMIC ASSESSMENT OF A COMBINED SLOW‐RELEASE METOPROLOL‐CHLORTHALIDONE PREPARATION (1981) (1)
THE EFFECTS OF FLOSEQUINAN AND NIFEDIPINE ON GLUOSE TOLERANCE IN HEALTHY VOLUNTEERS (1988) (1)
Coronary artery disease and antioxidants—is there a role for carvedilol? (1997) (1)
THERAPEUTIC PROGRESS‐REVIEW XXXV ASPIRIN IN THE NEXT DECADE (1989) (1)
Beta‐blockers in heart failure—a cardioprotective therapy? (1997) (1)
Treatment with beta-blockers--the value of an even plasma concentration over 24 h. (1997) (1)
Malabsorption inrheumatoid disease (1971) (1)
Pharmacokinetic and pharmacodynamic studies of single oral doses of metoprolol in normal volunteers (1977) (1)
Steady State Plasma Nifedipine Levels in Patients Attending a Hypertensive Clinic (1985) (1)
Increased Oxidative Stress in Ageing and Age-Related Diseases (1998) (1)
Exercise metabolism inhealthy volunteers taking atenolol, highandlowdosesofmetoprolol CR/ZOK,andplacebo (1994) (0)
The Measurement of Na+, K+-Atpase Activity Using Bioluminescence (1985) (0)
The lipolytic effect of r- and 2-adrenoceptor activation in healthy human volunteers (2006) (0)
Letter: Medical management of transient ischaemic attacks. (1975) (0)
Rheumatoid liver? (1970) (0)
CALCIUM ANTAGONISTS AND ISCHAEMIC HEART DISEASE (1987) (0)
Angina and its treatment (1999) (0)
Theinfluence ofageon thexylose absorption test (1970) (0)
Intestinal motility and absorption. (1973) (0)
Raynaud ' s phenomenon . trinitrate in secondary vasospasm by glyceryl Objective relief of (2008) (0)
Single dose and steady state pharmacokinetic study on methaqualone (1976) (0)
DEMENTIA–FURTHER PROGRESS (1987) (0)
Plasma Levels and Negative Chronotropic Effect of Metoprolol following Single Doses of a Conventional and Sustained Release Formulation C. P. Quarterman, M. J. Kendall, R. G. Welling vol. 15, 97–103 (1979) (1979) (0)
THERAPEUTIC PROGRESS—REVIEW XVIII ALZHEIMER'S DISEASE (1985) (0)
Vitamin E supplementation [1] (multiple letters) (2001) (0)
Cardioprotection: Overview (1991) (0)
Hypokalaemia and xipamide (1982) (0)
Erythrocyte Sodium Pump Activity in Diabetes Mellitus and its Relationship to Control and Microangiopathy (1985) (0)
The effects of combined treatment with b1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects (1997) (0)
Gliadin fractions in coeliac disease. (1973) (0)
Proceedings: The effect of age on plasma pethidine concentrations. (1974) (0)
GLIADIN FRACTIONS IN CŒLIAC DISEASE (1973) (0)
Fixed dose beta-blocker diuretic combinations. (1985) (0)
Prevention of sudden cardiac death (1994) (0)
Nitric Oxide Activity is Enhanced following Ingestion of Red Wine (2002) (0)
The Beta-1-Selectivity of Nebivolol, a vasodilating ß-blocker (2003) (0)
Regional considerations in the use of antihypertensive combinations (1995) (0)
Oxidative Stress and Endothelial Damage in Chronic Heart Failure: Effects of Carvedilol and Bisoprolol (2001) (0)
Beta-blockers: recognising the assets in relation to coronary artery disease (2000) (0)
Cardiac rehabilitation. (1993) (0)
Change in Plasma ANP Immunoreactivity during Ultrafiltration and Haemodialysis (1986) (0)
The HOT Study. Hypertension Optimal Therapy. (1998) (0)
Malabsorption in rheumatoid disease 627 (0)
2845 – PHARMACOKINETIC STUDIES WITH ANTRAFENINE IN MAN (1978) (0)
Formation of Peroxynitrite following An Infusion of L-Arginine in Healthy Volunteers (2003) (0)
Abnormal LDL subfraction profiles in renal transplant recipients. (1996) (0)
Spontaneous fracture of pelvis in rheumatoid arthritis. (1972) (0)
PATHOPHYSIOLOGY OF HYPERTENSION IN DIABETES MELLITUS—IMPLICATIONS FOR MANAGEMENT (1991) (0)
THE DIURETIC EFFECT OF BENDROFLUAZIDE, ALONE AND WITH TRIAMTERENE (1980) (0)
Nadolol in combination with indapamide and xipamide in resistant hypertensives (2004) (0)
Reducing adverse drug reactions (2017) (0)
Owen Lyndon Wade (2009) (0)
Hypertension, coronary artery disease and insulin resistance—linked disorders with an impact on treatment (1992) (0)
Hypertension in Diabetes Mellitus: Role of β-Blockers: The Authors’ Reply (2001) (0)
THE EFFECTS OF DRUGS AND DISEASE ON LIVER FUNCTION TESTS (1980) (0)
Theimpact ofashort course ofthree lipid lowering drugs onfatoxidation during exercise inhealthy volunteers (1993) (0)
Fat Metabolism during One Hours Exercise on High and Low Doses of Propranolol, Metoprolol or Placebo (1994) (0)
Effect of Propranolol on Serum Free T4 and Free T3 in Healthy Subjects (1984) (0)
CAN THE BIOCHEMICAL RESPONSES TO A 32-ADRENOCEPTOR STIMULANT BE USED TO ASSESS THE SELECTIVITY OF f3-ADRENOCEPTOR BLOCKERS? (2006) (0)
Charles Dickens' favourite child and a new kind of ray (2016) (0)
Erratum to Controlled Release Metoprolol (1992) (0)
Letter: Reappraisal of the xylose test. (1975) (0)
IS DIURETIC‐INDUCED HYPOKALAEMIA CLINICALLY IMPORTANT? (1983) (0)
synovial fluid analysis . features and blood and activity based on clinical Assessment of rheumatoid (0)
Blood pressure – lower targets, greater challenges (2003) (0)
IMMORTALITY FOR OLD DRUGS (1984) (0)
Beta-Adrendceptors Mediated Responses and Age (1982) (0)
Metoprolol CR/ZOK (1990) (0)
CLINICAL SIGNIFICANCE—CHICKEN OR EGG? (1989) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Martin John Kendall?

Martin John Kendall is affiliated with the following schools:

University of Birmingham

Martin John Kendall's Academic­Influence.com Rankings

Martin John Kendall's Degrees

Similar Degrees You Can Earn

Why Is Martin John Kendall Influential?

Martin John Kendall's Published Works

Published Works

What Schools Are Affiliated With Martin John Kendall?

Martin John Kendall's AcademicInfluence.com Rankings